http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2013251237-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6f4d86235703b3e2a1cb10b98722d80d |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675 |
filingDate | 2013-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc4531fe73cf508960974f9efb81d9aa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54b48ff45313c01476d8ff15a27ffc4c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de520b1681caaca8fb45bdd2ac855d3e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b410b8569e8c9131cc0b000fc954749b |
publicationDate | 2013-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | AU-2013251237-A1 |
titleOfInvention | Bitherapy and tritherapy used for treating an HIV-positive patient |
abstract | COMPOSITION AND PROCESSES FOR USE IN AN ANTI-HIV This invention relates to a composition comprising an anti-HIV treatment and a treatment for side effects of said anti-HIV treatment in an HIV-infected patient. This 5 invention is, for example, very useful in the treatment of side effects caused by certain anti-HIV treatments, for example premature aging and lipodystrophy, which can be caused by protease inhibitors or reverse transcriptase inhibitors. The composition of this invention includes at 10 least one hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor, at least one farnesyl-pyrophosphate synthase inhibitor, and at least one anti-HIV agent. One of the processes for treating an HIV-infected patient includes, in any order, the following steps: (i) 15 administration of a mixture including at least one hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor and at least one farnesyl-pyrophosphate synthase inhibitor and (ii) administration of an anti-HIV agent, in which the administrations are concomitant, 20 successive or alternative. 4813779_1 (GHMallers) P84540.AU.1 |
priorityDate | 2008-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1542.